Advertisement
Advances in Pediatrics

Update on Pediatric Epilepsy

      The understanding of seizures and epilepsy has grown tremendously in the past decade, and many more treatment options have become available. Yet, pediatric epilepsy still remains a great challenge for clinicians to manage. This article describes how seizures and epilepsy are understood and classified today and how to approach the management of patients with seizures and updates the pediatrician on the newest approaches to epilepsy treatment.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Pediatrics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Fisher R.S.
        • van Emde Boas W.
        • Blume W.
        • et al.
        Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE).
        Epilepsia. 2005; 46: 470-472
        • Chung S.S.
        • Gerber P.
        • Kirlin K.A.
        Ictal eye closure is a reliable indicator for psychogenic nonepileptic seizures.
        Neurology. 2006; 66: 1730-1731
        • Berg A.T.
        • Berkovic S.F.
        • Brodie M.J.
        • et al.
        Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009.
        Epilepsia. 2010; 51: 676-685
      1. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy.
        Epilepsia. 1989; 30: 389-399
        • Devinsky O.
        Effects of seizures on autonomic and cardiovascular function.
        Epilepsy Curr. 2004; 4: 43-46
        • Freeman J.H.
        Practice parameter: evaluating a first nonfebrile seizure in children: report of the quality standards subcommittee of the American academy of neurology, the child neurology society, and the American epilepsy society.
        Neurology. 2001; 56: 574
        • Hirtz D.
        • Berg A.
        • Bettis D.
        • et al.
        Practice parameter: treatment of the child with a first unprovoked seizure: report of the quality standards subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
        Neurology. 2003; 60: 166-175
        • Arzimanoglou A.
        • Ben-Menachem E.
        • Cramer J.
        • et al.
        The evolution of antiepileptic drug development and regulation.
        Epileptic Disord. 2010; 12: 3-15
        • Bialer M.
        • White H.S.
        Key factors in the discovery and development of new antiepileptic drugs.
        Nat Rev Drug Discov. 2010; 9: 68-82
        • Kwan P.
        • Brodie M.J.
        Early identification of refractory epilepsy.
        N Engl J Med. 2000; 342: 314-319
        • Benbadis S.R.
        • WO Tatum
        • Gieron M.
        Idiopathic generalized epilepsy and choice of antiepileptic drugs.
        Neurology. 2003; 61: 1793-1795
        • Bilo L.
        • Meo R.
        Polycystic ovary syndrome in women using valproate: a review.
        Gynecol Endocrinol. 2008; 24: 562-570
        • Glauser T.
        • Kluger G.
        • Sachdeo R.
        • et al.
        Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome.
        Neurology. 2008; 70: 1950-1958
        • Wheless J.W.
        • Vazquez B.
        Rufinamide: a novel broad-spectrum antiepileptic drug.
        Epilepsy Curr. 2010; 10: 1-6
        • Ben-Menachem E.
        • Biton V.
        • Jatuzis D.
        • et al.
        Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures.
        Epilepsia. 2007; 48: 1308-1317
        • Eling P.
        • Renier W.O.
        • Pomper J.
        • et al.
        The mystery of the Doctor’s son, or the riddle of West syndrome.
        Neurology. 2002; 58: 953-955
        • Pellock J.M.
        • Hrachovy R.
        • Shinnar S.
        • et al.
        Infantile spasms: a U.S. consensus report.
        Epilepsia. 2010; 51: 2175-2189
        • Go C.Y.
        • Snead O.C.
        Adrenocorticotropin and steroids.
        in: Wyllie E. Wyllie’s treatment of epilepsy: principles and practice. Lippincott Williams and Wilkins, Philadelphia (PA)2010: 763-770
        • Chiron C.
        • Dumas C.
        • Jambaque I.
        • et al.
        Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis.
        Epilepsy Res. 1997; 26: 389-395
        • Lerner J.T.
        • Salamon N.
        • Sankar R.
        Clinical profile of vigabatrin as monotherapy for treatment of infantile spasms.
        Neuropsychiatr Dis Treat. 2010; 6: 731-740
        • Eke T.
        • Talbot J.F.
        • Lawden M.C.
        Severe persistent visual field constriction associated with vigabatrin.
        BMJ. 1997; 314: 180-181
      2. Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America’s Working Group on Status Epilepticus.
        JAMA. 1993; 270: 854-859
        • Shinnar S.
        • Hesdorffer D.C.
        • Nordli Jr., D.R.
        • et al.
        Phenomenology of prolonged febrile seizures: results of the FEBSTAT study.
        Neurology. 2008; 71: 170-176
        • Lowenstein D.H.
        The management of refractory status epilepticus: an update.
        Epilepsia. 2006; 47: 35-40
        • Kossoff E.H.
        • Zupec-Kania B.A.
        • Rho J.M.
        Ketogenic diets: an update for child neurologists.
        J Child Neurol. 2009; 24: 979-988
        • Cross J.H.
        • McLellan A.
        • Neal E.G.
        • et al.
        The ketogenic diet in childhood epilepsy: where are we now?.
        Arch Dis Child. 2010; 95: 550-553
        • Lefevre F.
        • Aronson N.
        Ketogenic diet for the treatment of refractory epilepsy in children: a systematic review of efficacy.
        Pediatrics. 2000; 105: E46
        • Neal E.G.
        • Chaffe H.
        • Schwartz R.H.
        • et al.
        The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial.
        Lancet Neurol. 2008; 7: 500-506
        • Zupec-Kania B.A.
        • Spellman E.
        An overview of the ketogenic diet for pediatric epilepsy.
        Nutr Clin Pract. 2008 Dec–2009 Jan; 23: 589-596
        • Freeman J.M.
        • Kossoff E.H.
        Ketosis and the ketogenic diet, 2010: advances in treating epilepsy and other disorders.
        Adv Pediatr. 2010; 57: 315-329
        • Kossoff E.H.
        • Zupec-Kania B.A.
        • Amark P.E.
        • et al.
        Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic diet study group.
        Epilepsia. 2009; 50: 304-317
        • Martinez C.C.
        • Pyzik P.L.
        • Kossoff E.H.
        Discontinuing the ketogenic diet in seizure-free children: recurrence and risk factors.
        Epilepsia. 2007; 48: 187-190
        • Zabara J.
        Inhibition of experimental seizures in canines by repetitive vagal stimulation.
        Epilepsia. 1992; 33: 1005-1012
        • Wheless J.
        Vagus nerve stimulation therapy.
        in: Wyllie E. Wyllie’s treatment of epilepsy: principles and practice. Lippincott Williams and Wilkins, 2010: 797-808
        • Naritoku D.
        Vagus Nerve Stimulation.
        in: Rho J. Sankar R. Cavazos J. Epilepsy: Scientific Foundations of Clinical Practice. Marcel Dekker, Inc, New York (NY)2004: 285-298
        • Handforth A.
        • DeGiorgio C.M.
        • Schachter S.C.
        • et al.
        Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial.
        Neurology. 1998; 51: 48-55
        • Ben-Menachem E.
        • Manon-Espaillat R.
        • Ristanovic R.
        • et al.
        Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. First International Vagus Nerve Stimulation Study Group.
        Epilepsia. 1994; 35: 616-626
        • DeGiorgio C.M.
        • Schachter S.C.
        • Handforth A.
        • et al.
        Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures.
        Epilepsia. 2000; 41: 1195-1200
        • Fisher R.S.
        • Handforth A.
        Reassessment: vagus nerve stimulation for epilepsy: a report of the therapeutics and technology assessment subcommittee of the American academy of neurology.
        Neurology. 1999; 53: 666-669